Recently, Hangauer and coworkers demonstrated that DTPs that arise upon lapatinib treatment of a HER2-amplified BC cell line displayed CD133 and CD44 upregulation and antioxidant-gene downregulation, showing a specific dependency on lipid hydroperoxidase GPX4 (glutathione peroxidase 4) for survival. The gene discussed is CD44; the disease is breast cancer.